Evidence map›Paper›PMID 34218441›Full record

ArticleJournal of leukocyte biology2022

The Akt-mTORC1 pathway mediates Axl receptor tyrosine kinase-induced mesangial cell proliferation.

Yuxuan Zhen, Tracy L McGaha, Fred D Finkelman, Wen-Hai Shao

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yuxuan ZhenDivision of Immunology, Allergy and Rheumatology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Tracy L McGahaPrincess Margaret Cancer Center, Tumor Immunotherapy Program, University Health Network, Toronto, ONT, M5G 2M9, Canada.
Fred D FinkelmanDivision of Immunology, Allergy and Rheumatology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Wen-Hai ShaoDivision of Immunology, Allergy and Rheumatology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
University of Cincinnati · USUniversity of Toronto · CA

Funding

Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAbR01AI145991 · NIAID · UNIVERSITY OF CINCINNATI · PI FINKELMAN, FRED DOUGLASS, KHODOUN, MARAT · 2019 to 2023
$2.6M
Wimpy antibody isotypes protect against antibody-mediated diseaseR01AI130103 · NIAID · UNIVERSITY OF CINCINNATI · PI FINKELMAN, FRED DOUGLASS · 2017 to 2021
$1.8M
Suppression of IgE-Mediated Disease by Polyclonal Rapid DesensitizationR01AI113162 · NIAID · UNIVERSITY OF CINCINNATI · PI FINKELMAN, FRED DOUGLASS · 2014 to 2017
$1.6M
Axl receptor tyrosine kinase, a potential therapeutic target in glomerulonephritisR01DK116789 · NIDDK · UNIVERSITY OF CINCINNATI · PI SHAO, WEN-HAI · 2019 to 2021
$710k
NIAID NIH HHS R01 AI113162NIAID NIH HHS R01 AI130103NIAID NIH HHS R01 AI145991NIDDK NIH HHS R01 DK116789
6 · The paper itself

Abstract

Glomerulonephritis (GN), an important pathologic feature of many renal diseases, is frequently characterized by mesangial cell proliferation. We and others have previously shown that the TAM family receptor tyrosine kinases Axl, Mer, and Tyro-3 contribute to cell survival, proliferation, migration, and clearance of apoptotic cells (ACs); that Axl contributes to GN by promoting mesangial cell proliferation; and that small molecule inhibition of Axl ameliorates nephrotoxic serum-induced GN in mice. We now show that stimulation of renal mesangial cell Axl causes a modest increase in intracellular Ca

Indexed as

GlomerulonephritisProto-Oncogene Proteins c-aktAnimalsAxl Receptor Tyrosine KinaseCell Proliferationc-Mer Tyrosine KinaseFemaleHumansIntercellular Signaling Peptides and ProteinsMaleMechanistic Target of Rapamycin Complex 1MiceNF-kappa BProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesTOR Serine-Threonine KinasesAxl Receptor Tyrosine Kinasec-Mer Tyrosine KinaseIntercellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 1NF-kappa BProto-Oncogene ProteinsProto-Oncogene Proteins c-aktReceptor Protein-Tyrosine KinasesTOR Serine-Threonine Kinasesapoptotic cell clearanceAxlmesangial cell proliferationmTORC1NF-κBTAM receptors

Identifiers

PMID34218441
PMCPMC9328168
OpenAlexW3181911204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.